Cite
HARVARD Citation
Scheen, A. (2020). Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. Expert opinion on drug safety. 19 (3), pp. 243-256. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Scheen, A. (2020). Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. Expert opinion on drug safety. 19 (3), pp. 243-256. [Online].